你即將離開本站

並前往https://twitter.com/nejm/status/1178431759152799745

NEJM on Twitter: "Patients w/ a progressive interstitial lung ...

... treated with nintedanib had a lower rate of loss of forced vital capacity than those given placebo. See the INBUILD trial.

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.